Benzinga – by Avi Kapoor, Benzinga Staff Writer.
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 150 points on Monday.
Shares of Harpoon Therapeutics, Inc.(NASDAQ: HARP) rose sharply in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share.
Harpoon Therapeutics shares jumped 98.6% to $20.95 in pre-market trading.
Here are some big stocks recording gains in today’s pre-market trading session.
- Heron Therapeutics, Inc. (NASDAQ: HRTX) shares rose 14.1% to $2.02 in pre-market trading. Heron Therapeutics announced a five-year distribution partnership with CrossLink Life Sciences to expand promotional effort for ZYNRELEF.
- Better Home & Finance Holding Company (NASDAQ: BETR) surged 11.2% to $0.7470 in pre-market trading.
- Sabre Corporation (NASDAQ: SABR) climbed 5.1% to $4.57 in pre-market trading.
- Cronos Group Inc. (NASDAQ: CRON) gained 4.1% to $2.27 in pre-market trading after…
